Skip to main content
. 2004 Dec 21;92(2):278–283. doi: 10.1038/sj.bjc.6602320

Table 3. Relative expression levels of TADG-15 mRNA in normal ovaries and ovarian carcinomas.

Tissue type N TADG-15 (mean±s.d.)a
Normal ovary 7 0.19±0.19b
Ovarian carcinoma 51 1.76±0.47b
 Clinical stage of carcinoma    
  Stage I 21 1.98±0.57c
  Stage II/III/IV 30 1.61±0.32c
a

s.d.=standard deviation.

b

Normal vs carcinoma; P<0.0001.

c

Stage I vs stage II/III/IV; P=0.0053.

All P-values were calculated using an unpaired t-test.